• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number ECH060040
Device Problems Partial Blockage (1065); Peeled/Delaminated (1454)
Patient Problems Occlusion (1984); No Known Impact Or Consequence To Patient (2692)
Event Date 09/06/2019
Event Type  Injury  
Manufacturer Narrative
All device lot numbers were investigated and the lots met pre-release specifications.The remaining for devices are as follows: ech060040 5662203pp022 udi: (b)(4), ech060040 5675645pp004 udi: (b)(4), ech060040 5675645pp017 udi: (b)(4), ech060040 5633976pp018 udi: (b)(4).
 
Event Description
The following information was reported to gore: on (b)(6) 2018 a patient was underwent a procedure for arterio-venous access in the forearm with a gore® acuseal vascular graft.The procedure was completed successfully.On (b)(6) 2019 following a dialysis session the graft was found to be stenosed for several cm at the inflow site.Because of the risk for total occlusion, a graft bypass was planned.On (b)(6) 2019 the patient underwent open bypass surgery using a gore® propaten® vascular graft.The gore® acuseal vascular graft remains implanted.
 
Event Description
The following information was reported to gore: on (b)(6) 2018 a patient was underwent a procedure for arterio-venous access in the forearm with a gore® acuseal vascular graft.The procedure was completed successfully.On (b)(6) 2019 following a dialysis session the graft was found to be stenosed for several cm at the inflow site.Because of the risk for total occlusion, a graft bypass was planned.On (b)(6) 2019 the patient underwent open bypass surgery using a gore® propaten® vascular graft.During the procedure, some disruption of the graft layers of the gore® acuseal vascular graft were observed.The gore® acuseal vascular graft remains implanted.No adverse events have been reported following this procedure.
 
Manufacturer Narrative
Additional information was received making this event reportable.The report fields have been repopulated in this follow-up.H.6.Results code 1: 213: the exact lot number could not be determined, however 5 devices were available for use at the time of the implantation.All device lot numbers were investigated and the lots met pre-release specifications.The remaining for devices are as follows: ech060040 5662203pp022 udi: (b)(4); ech060040 5675645pp004 udi: (b)(4); ech060040 5675645pp017 udi: (b)(4); ech060040 5633976pp018 udi: (b)(4), w.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Manufacturer Narrative
H.1.Medwatch # 2017233-2019-00976 was sent in error.Additional received information determined that this event is not reportable to the fda and therefore the medwatch is being retracted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9148018
MDR Text Key162315780
Report Number2017233-2019-00976
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 11/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/06/2020
Device Catalogue NumberECH060040
Device Lot Number5633976PP021
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/02/2019
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received10/28/2019
12/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
-
-